【制药网 医药股市】10 月 15 日，港交所交易行情再现波澜：四环医药旗下轩竹生物挂牌上市，开盘即高开 153.97%，盘中涨幅一度突破 160%，最终以 126.72% 的惊人涨幅收市，总市值飙升至 136.2 亿港元。这并非孤例，此前银诺医药上市首日暴涨 206.48%，劲方医药亦收获 106.47% 的首日涨幅，多只医药新股集体翻倍，其中不乏轩竹生物这样曾折戟科创板的企业。在医药行业估值...
Source Link【制药网 医药股市】10 月 15 日，港交所交易行情再现波澜：四环医药旗下轩竹生物挂牌上市，开盘即高开 153.97%，盘中涨幅一度突破 160%，最终以 126.72% 的惊人涨幅收市，总市值飙升至 136.2 亿港元。这并非孤例，此前银诺医药上市首日暴涨 206.48%，劲方医药亦收获 106.47% 的首日涨幅，多只医药新股集体翻倍，其中不乏轩竹生物这样曾折戟科创板的企业。在医药行业估值...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.